Virogin Biotech Funding: $281M Raised, Series D (2021)
Virogin Biotech is based in Vancouver, Canada. It has raised $281M in total funding. Latest round: Series D.
Virogin Biotech funding overview
Virogin Biotech is based in Vancouver, Canada. Virogin Biotech has raised $281M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series D announced in September 2021. The round record for Virogin Biotech runs through 2021; nothing later has been disclosed. Investors on record include Korea Investment Holdings, GF Securities, SDIC, Shenzhen Capital Group, CMG-SDIC Capital, CDH Investments and 5 others. 11 distinct backers are named across the disclosed rounds.
Virogin Biotech at a glance
Total raised
$281M
Latest round
Series D
Latest round date
September 2021
Headquarters
Vancouver, Canada
Notable investors
Korea Investment Holdings, GF Securities, SDIC, Shenzhen Capital Group, CMG-SDIC Capital, CDH Investments, Lingdao Capital, Panlin Capital
Frequently asked about Virogin Biotech funding
How much has Virogin Biotech raised?
Virogin Biotech has raised $281M in total disclosed funding across the rounds on record.
Who has invested in Virogin Biotech?
Korea Investment Holdings, GF Securities, SDIC, Shenzhen Capital Group, CMG-SDIC Capital, CDH Investments are named among the investors backing Virogin Biotech.
What was the latest Virogin Biotech funding round?
The most recent disclosed round is a Series D, announced in September 2021.
Where is Virogin Biotech based?
Virogin Biotech is based in Vancouver, Canada.
When did Virogin Biotech last raise?
The last disclosed Virogin Biotech round closed in September 2021 at Series D.
Round data for Virogin Biotech is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Vancouver and backer lists below.
